Gene · 654
Papers3,545
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 3,545
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Distinct CholinomiR Blood Cell Signature as a Potential Modulator of the Cholinergic System in Women with Fibromyalgia Syndrome. | Cells | 2022 | 35455956 | PubTator, text mining | PubMed |
| Histone Demethylase KDM5C Drives Prostate Cancer Progression by Promoting EMT. | Cancers (Basel) | 2022 | 35454801 | PubTator, text mining | PubMed |
| Cytokine Profile and Anti-Inflammatory Activity of a Standardized Conditioned Medium Obtained by Coculture of Monocytes and Mesenchymal Stromal Cells (PRS CK STORM). | Biomolecules | 2022 | 35454123 | PubTator, text mining | PubMed |
| Environmental induced transgenerational inheritance impacts systems epigenetics in disease etiology. | Sci Rep | 2022 | 35440735 | PubTator, text mining | PubMed |
| Application of BMP in Bone Tissue Engineering. | Front Bioeng Biotechnol | 2022 | 35433652 | PubTator, text mining | PubMed |
| MicroRNA-21 induces cisplatin resistance in head and neck squamous cell carcinoma. | PLoS One | 2022 | 35421166 | PubTator, text mining | PubMed |
| Challenges to Improve Bone Healing Under Diabetic Conditions. | Front Endocrinol (Lausanne) | 2022 | 35418946 | PubTator, text mining | PubMed |
| Non-erythropoiesis-stimulating agent, non-iron therapies for the management of anaemia: protocol for a scoping review. | BMJ Open | 2022 | 35410937 | PubTator, text mining | PubMed |
| Biodegradable Microparticles for Regenerative Medicine: A State of the Art and Trends to Clinical Application. | Polymers (Basel) | 2022 | 35406187 | PubTator, text mining | PubMed |
| Connective tissue growth factor mediates bone morphogenetic protein 2-induced increase in hyaluronan production in luteinized human granulosa cells. | Reprod Biol Endocrinol | 2022 | 35395768 | PubTator, text mining | PubMed |
| Platelet Derived Vesicles Enhance the TGF-beta Signaling Pathway of M1 Macrophage. | Front Endocrinol (Lausanne) | 2022 | 35370988 | PubTator, text mining | PubMed |
| The Multifaceted Neurotoxicity of Astrocytes in Ageing and Age-Related Neurodegenerative Diseases: A Translational Perspective. | Front Physiol | 2022 | 35370777 | PubTator, text mining | PubMed |
| Hydrostatic pressure facilitates calcium deposition and osteogenic gene expression in the osteoblastic differentiation of placenta-derived multipotent cells. | Taiwan J Obstet Gynecol | 2022 | 35361387 | PubTator, text mining | PubMed |
| Functional and Immune Modulatory Characteristics of Bone Marrow Mesenchymal Stromal Cells in Patients With Aplastic Anemia: A Systematic Review. | Front Immunol | 2022 | 35355996 | PubTator, text mining | PubMed |
| Hydrogel-Mediated Release of TRPV1 Modulators to Fine Tune Osteoclastogenesis. | ACS Omega | 2022 | 35350319 | PubTator, text mining | PubMed |
| Repair of a Rat Mandibular Bone Defect by Hypertrophic Cartilage Grafts Engineered From Human Fractionated Adipose Tissue. | Front Bioeng Biotechnol | 2022 | 35350180 | PubTator, text mining | PubMed |
| Integrative analyses of biomarkers and pathways for heart failure. | BMC Med Genomics | 2022 | 35346191 | PubTator, text mining | PubMed |
| Exosomal lncRNA and mRNA profiles in polycystic ovary syndrome: bioinformatic analysis reveals disease-related networks. | Reprod Biomed Online | 2022 | 35337736 | PubTator, text mining | PubMed |
| A Review of In Vivo and Clinical Studies Applying Scaffolds and Cell Sheet Technology for Periodontal Ligament Regeneration. | Biomolecules | 2022 | 35327627 | PubTator, text mining | PubMed |
| Therapeutic Approaches Targeting Proteins in Tumor-Associated Macrophages and Their Applications in Cancers. | Biomolecules | 2022 | 35327584 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/654/papers?page=38